-
Traditional disease management programs that help patients manage their diseases after they become costly are like arriving at the scene of an accident that has already happened, John Palumbo asserts.
-
When case managers at Highmark Blue Cross and Blue Shield bring up advance directives with their patients, they are well prepared.
-
End-of-life care may be the most difficult subject youll take up with your clients, but youll be doing them a big disservice if you dont discuss it.
-
When Jeanne Musolf, MS, RN, CCM, talks with new employees about the inpatient case management program at Childrens Hospital of Wisconsin, she often tells them, expect that how things are currently will not be how they are six months from now. Were always trying to improve and change.
-
At Sarasota (FL) Memorial Hospital, discharge planners dont spend a lot of time checking off boxes to document each individual task they have performed.
-
While many case management organizations are struggling to demonstrate the contributions they make to patient care, reimbursement, and cost containment, the integrated case management department at Sarasota (FL) Memorial Hospital has overcome the barrier and can demonstrate with confidence how it contributes to organizational success.
-
For years, health care managers have been reworking documentation forms trying to streamline the process to make it fast and efficient to increase compliance. No one ever designed the perfect form.
-
Reducing patient length of stay (LOS) from nearly seven days to the regional average of 5.5 days usually takes two years, according to the Health Care Advisory Board, a nationally recognized organization that provides best practices research and analysis to the health care industry.
-
Discharge planners at some facilities apparently are either unaware of or are ignoring a federal requirement that hospitals offer patients a choice of home care providers and that they tell patients when there is a financial interest between the hospital and an agency to which the patient is being referred.
-
Reversing Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) is a prospective, randomized, controlled trial assessing the effectiveness of an intensive or aggressive lipid-lowering approach
(atorvastatin 80 mg) to a moderate one (pravastatin 40 mg).